RCKTRocket Pharmaceuticals, Inc.

RCKT Stock Price, Valuation & Chart | Rocket Pharmaceuticals, Inc.

Compare

$3.860+0.13 (+3.49%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology RCKT intrinsic value RCKT calculated fair value vs price

Overview Financials Dividends Ratios

RCKT Historical price chart

RCKT Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization421.49M

PE Ratio-22.71

EPS-0.17

Trading Volume1.16M

Today's High/Low3.95/3.71

Dividend Yield0.00

52 Week High/Low5.45/2.53

Shares Outstanding109.19M

RCKT Financial Statement

RCKT Analyst ratings

RCKT Analysis & performance metrics

RCKT Company profile

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and…

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty…

RCKT Management team

Name

Position

Kevin GiordanoCTO

Director of Corporate Communications

Kinnari Patel M.B.A., Pharm.D.COO

Head of R&D, President & Chief Operating Officer

Sarbani Chaudhuri M.B.A.

Chief Commercial & Medical Affairs Officer

Aaron OndreyCFO

Chief Financial Officer

Gaurav D. Shah M.D.CEO

Chief Executive Officer & Director

Jonathan Schwartz M.D.

Chief Medical & Gene Therapy Officer

Gayatri R. Rao J.D., M.D.

Senior Vice President of Clinical Safety & Chief Regulatory Officer

Isabel Carmona J.D.

Chief People Officer

Name

Position

Kevin GiordanoCTO

Director of Corporate Communications

Kinnari Patel M.B.A., Pharm.D.COO

Head of R&D, President & Chief Operating Officer

Sarbani Chaudhuri M.B.A.

Chief Commercial & Medical Affairs Officer

Aaron OndreyCFO

Chief Financial Officer

Gaurav D. Shah M.D.CEO

Chief Executive Officer & Director

Jonathan Schwartz M.D.

Chief Medical & Gene Therapy Officer

Gayatri R. Rao J.D., M.D.

Senior Vice President of Clinical Safety & Chief Regulatory Officer

Isabel Carmona J.D.

Chief People Officer

Management Team

Kevin GiordanoCTO

Director of Corporate Communications

Kinnari Patel M.B.A., Pharm.D.COO

Head of R&D, President & Chief Operating Officer

Sarbani Chaudhuri M.B.A.

Chief Commercial & Medical Affairs Officer

Aaron OndreyCFO

Chief Financial Officer

Gaurav D. Shah M.D.CEO

Chief Executive Officer & Director

Jonathan Schwartz M.D.

Chief Medical & Gene Therapy Officer

Gayatri R. Rao J.D., M.D.

Senior Vice President of Clinical Safety & Chief Regulatory Officer

Isabel Carmona J.D.

Chief People Officer

Management

Kevin GiordanoCTO

Director of Corporate Communications

Kinnari Patel M.B.A., Pharm.D.COO

Head of R&D, President & Chief Operating Officer

Sarbani Chaudhuri M.B.A.

Chief Commercial & Medical Affairs Officer

Aaron OndreyCFO

Chief Financial Officer

Gaurav D. Shah M.D.CEO

Chief Executive Officer & Director

Jonathan Schwartz M.D.

Chief Medical & Gene Therapy Officer

Gayatri R. Rao J.D., M.D.

Senior Vice President of Clinical Safety & Chief Regulatory Officer

Isabel Carmona J.D.

Chief People Officer

Total 8 executives

RCKT Frequently asked questions

What is Rocket Pharmaceuticals, Inc. (RCKT) Stock Price?

Current stock price of Rocket Pharmaceuticals, Inc. (RCKT) stock is $3.860. The stock price is +3.49% higher in the session. The intraday range can be seen from this page. Volume of Rocket Pharmaceuticals, Inc. (RCKT) stock is 1.16M.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Rocket Pharmaceuticals, Inc. (RCKT) stock price going up or down today?

The stock price of Rocket Pharmaceuticals, Inc. (RCKT) can change with earnings, company news, and overall market sentiment. Rocket Pharmaceuticals, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Rocket Pharmaceuticals, Inc. stock expensive at its current price?

Whether Rocket Pharmaceuticals, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for RCKT on this page is -22.71. EPS on this page is -0.17. Compare those figures with peers and growth expectations before deciding if the current Rocket Pharmaceuticals, Inc. price is justified.

How has the stock price of Rocket Pharmaceuticals, Inc. (RCKT) performed historically?

Historical performance for Rocket Pharmaceuticals, Inc. (RCKT) is shown on the price chart on this page. Review multi-period moves alongside volume to see how RCKT reacted to past earnings and market events.

Should I buy Rocket Pharmaceuticals, Inc. (RCKT) stock, at this price?

Buying Rocket Pharmaceuticals, Inc. (RCKT) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.